Aldeyra Therapeutics Inc (NASDAQ: ALDX) announced a demonstration of target engagement and improvement in the signs of alcohol intoxication in the Phase 2 trial of ADX-629. Relative to the placebo, ...
The medical record for Mrs. Smith indicated a normal neurologic examination with negative Romberg test and intact proprioception, reflexes, and light touch sensation, but the Dix-Hallpike maneuver had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback